HIGHLIGHTS
- who: Matilde Buzzi and collaborators from the Department of Biomedical Sciences, Humanitas University, Milan, Italy have published the article: The Short-Term Results of Autologous Platelet-Rich Plasma as an Adjuvant to Re-Intervention in the Treatment of Refractory Full-Thickness Macular Holes, in the Journal: (JOURNAL)
- what: The aim of this study was to investigate the short-term efficacy and safety of autologous platelet-rich plasma (a-PRP) as an adjuvant to revisional vitrectomy for refractory (rFTMHs). The study was conducted per the tenets of the Declaration of Helsinki, Institutional review board approval was . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.